News About: Pharm. Industry
C&C Research Laboratories to develop 3 new drugs
C&C Research Laboratories said Monday it will develop anti-gout drug (UR-1102), anticancer drug and anti-inflammatory agent.
C&C Research Laboratories was established in 1992 for the purpose of drug discovery on th...
Kim So-hee named marketing director of Gilead Science Korea
Kim So-hee has been named marketing director of Gilead Science Korea, the company said Monday.
A graduate of Sookmyung Women’s University, she worked for MSD Korea in 1997 and served as marketing head of BMS Korea ...
Government to select 56 innovative drugmakers
The Ministry of Health and Welfare on Sunday announced it plans to enact a bill to legislate the government’s plan to designate “innovative pharmaceutical firms” that post more than 100 billion won in sales and invest...
Leading drugmakers are in distress over legal action
Korea’s major pharmaceutical firms are under fire due to their lukewarm attitude on legal action against the government’s price cut plan.
The government plans to slash the price of about half the drugs on the marke...
Lawsuit against drug price cut getting fierce
A legal suit, ignited by Korean pharmaceutical firms, is getting fiercer as GUJU pharm and YOUNG POONG pharm unveiled their plans to defend their drug prices, which were reduced by the government’ anti-rebate rule, in...
Leading pharmaceutical firms criticized for passive legal action
The domestic leading pharmaceutical firms are under fire for their tepid attitude over legal action against the government’s plan to slash insured drug prices in April.
Dalim Biotech and KMS Pharma filed a legal su...
Smaller pharmaceutical firms to hit hardest by government’s price cut plan
A chief executive of one of the smaller drug-making companies in Korea expressed concern about the country’s pharmaceutical industry.
“The recent legal action by two small drug makers reflects their urgency for sur...
Cash dividends at drug firms soar to 15%
Cash dividends paid out by KOSPI-listed pharmaceutical companies reached by average 15 percent in 2011 from a year before, Yakup.com said yesterday.
A total of 19 KOSPI-listed drug firms paid cash dividends, with t...
Drugmakers struggle for survival
Domestic pharmaceutical companies have thus far had an easy life thanks to the government’s misguided drug pricing formula introduced more than a decade ago, according to the Ministry of Health and Welfare.
The min...
Ilsung Pharma under fire over delayed law action
Ilsung Pharmaceutical Co. is under fire after it failed to take a lead in legal action against the government over the latter’s plan to slash drug prices in April.
Industry sources said small-sized Dalim Biotech an...
